Nexon Pharmasp. z o.o.
Manufacture of homogenised food preparations and dietetic food
Overview
Nexon Pharma offers dietary supplements from the MEDIPROLAC line, including MEDIPROLAC IMMUNO, MEDIPROLAC IBEES, and MEDIPROLAC IMMUNO and MEDIPROLAC drops for children. Its portfolio also includes vitamins C, D3 + K2, D3, B12 and B Complex, as well as the EUPHRASIA ŚWIETLIK preparation.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2017-01-04. Active
37 1050 1012 1000 0090 8274 8295- 59 1050 1012 1000 0090 8274 8287
- 18 1050 1012 1000 0090 8281 2463
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Trademarks
Nexon Pharma holds 56 active trademarks registered with the Polish Patent Office. 25 applications are pending. 7 marks have expired or were not registered. The first mark was filed in 2017.
| Mark | Protected until | |
|---|---|---|
| TRANXILIUM(word) | Feb 20, 2036 | |
| ROlPLON(word) | Dec 3, 2035 | |
| BYSABEL(word) | Mar 20, 2035 | |
| ZENRA(word) | Aug 29, 2034 | |
| COVERCARD(word) | Aug 29, 2034 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Sławomir Radosław Bernaciak (55) | 30 | $405.19 | 30% |
Marzena Teresa Idzikowska (56) | 40 | $540.25 | 40% |
Agata Matylda Zalega Bernaciak (53) | 30 | $405.19 | 30% |
Agata Matylda Zalega Bernaciak and Sławomir Radosław Bernaciak hold a combined 60% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nikalabsp. z o.o. | $2,614,050.94 | nikalab.pl | ||
| Polmlek Internationalsp. z o.o. | $2,445,720.49 | polmlek.com | ||
| Bionatursp. z o.o. + limited partnership | $1,192,779.68 | bionatur.pl | ||
| Suplement.Iosp. z o.o. | $1,149,843.38 | suplement.io | ||
| Animal Nutraceuticalssp. z o.o. | $1,056,227.60 | animal-nutraceuticals.pl | ||
| IOCsp. z o.o. | $878,940.46 | producentsuplementow.pl | ||
| Pharmavenesp. z o.o. | $783,187.61 | pharmavene.com | ||
| Labs212sp. z o.o. | $675,204.60 | labs212.pl | ||
| Colostrum Polskasp. z o.o. | $587,012.72 | colostrumpolska.pl | ||
| Amberpharmsp. z o.o. | $300,044.02 | amberpharm.eu |
FAQ
Last updated: 2026-06-23